Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Mandala Multifinance Tbk. (MFIN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Mandala Multifinance Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Mandala Multifinance Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Mandala Multifinance Tbk. diperdagangkan di Rp890 (kapitalisasi pasar 4,45 T), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Mandala Multifinance Tbk. jauh lebih besar — sekitar 26,8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

MFINOBAT
Kapitalisasi Pasar
4,45 T166,01 M
Volume
324 rb
Lot
3,24 rb
Perputaran
77,68 jt
Harga Rata-rata
239,75
Nilai Transaksi
77,68 jt
Harga Ekuilibrium Indikatif
240
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MFIN
Lihat detail
OBAT
Lihat detail

Tentang Mandala Multifinance Tbk.

PT Mandala Multifinance Tbk (the Company) was established under its original name of PT Vidya Cipta Leasing Corporation on Aug 13th, 1983, then changed to PT Lautan Berlian Leasing at 1990. On 1996 company's name changed to PT Gracia Dinamika Mulifinance and in 1997 the name changed to PT Mandala Multifinance.The articles of association has been amended most recently by notarial deed no 34 dated 28 Apr 2005 concerning among others, the change in the company's name and public offering of stock.

Selengkapnya di halaman MFIN

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT